【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 15
2 Introduction 16
2.1 Cardiac Assist Devices Overview 16
3 Products under Development 18
3.1 Cardiac Assist Devices – Pipeline Products by Stage of Development 18
3.2 Cardiac Assist Devices – Pipeline Products by Segment 19
3.3 Cardiac Assist Devices – Pipeline Products by Territory 20
3.4 Cardiac Assist Devices – Pipeline Products by Regulatory Path 21
3.5 Cardiac Assist Devices – Pipeline Products by Estimated Approval Date 22
3.6 Cardiac Assist Devices – Ongoing Clinical Trials 23
4 Cardiac Assist Devices – Pipeline Products under Development by Companies 24
4.1 Cardiac Assist Devices Companies – Pipeline Products by Stage of Development 24
4.2 Cardiac Assist Devices – Pipeline Products by Stage of Development 27
5 Cardiac Assist Devices Companies and Product Overview 31
5.1 Abiomed, Inc. Company Overview 31
5.1.1 Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 Acorn Cardiovascular, Inc. Company Overview 37
5.2.1 Acorn Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.3 Arrow International Cr, A.S. Company Overview 40
5.3.1 Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview 40
5.4 Biophan Technologies, Inc. Company Overview 41
5.4.1 Biophan Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.5 BioQ Devices Pty Ltd Company Overview 43
5.5.1 BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
5.6 BioVentrix, Inc. Company Overview 44
5.6.1 BioVentrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.7 BiVacor Pty Ltd Company Overview 48
5.7.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Braile Biomedica Ltda. Company Overview 49
5.8.1 Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview 49
5.9 Calon Cardio-Technology Ltd Company Overview 50
5.9.1 Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
5.10 Cardiac Power Inc. Company Overview 53
5.10.1 Cardiac Power Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.11 CardiacAssist, Inc. Company Overview 54
5.11.1 CardiacAssist, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.12 Cardiak Ltd. Company Overview 57
5.12.1 Cardiak Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57
5.13 CARDIAnove Company Overview 58
5.13.1 CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview 58
5.14 Cardio Vox, Inc. Company Overview 59
5.14.1 Cardio Vox, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.15 CardioBridge GmbH Company Overview 60
5.15.1 CardioBridge GmbH Pipeline Products & Ongoing Clinical Trials Overview 60
5.16 CardioKinetix, Inc. Company Overview 63
5.16.1 CardioKinetix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.17 CardioPlus, Inc. Company Overview 67
5.17.1 CardioPlus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.18 Carmat SAS Company Overview 68
5.18.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 68
5.19 Charite – Universitatsmedizin Berlin Company Overview 72
5.19.1 Charite – Universitatsmedizin Berlin Pipeline Products & Ongoing Clinical Trials Overview 72
5.20 Cleveland Heart, Inc. Company Overview 73
5.20.1 Cleveland Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.21 CorasMedical Company Overview 76
5.21.1 CorasMedical Pipeline Products & Ongoing Clinical Trials Overview 76
5.22 CorAssist Cardiovascular Ltd. Company Overview 77
5.22.1 CorAssist Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 77
5.23 CorInnova, Inc. Company Overview 81
5.23.1 CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.24 CorWave Company Overview 86
5.24.1 CorWave Pipeline Products & Ongoing Clinical Trials Overview 86
5.25 Drexel University Company Overview 87
5.25.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 87
5.26 DUALIS MedTech GmbH Company Overview 88
5.26.1 DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 88
5.27 Ension, Inc. Company Overview 90
5.27.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.28 Evaheart, Inc. Company Overview 91
5.28.1 Evaheart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.29 Everheart Systems, LLC Company Overview 95
5.29.1 Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 95
5.30 Foster-Miller, Inc. (Inactive) Company Overview 96
5.30.1 Foster-Miller, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 96
5.31 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 97
5.31.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 97
5.32 Gold Medical Technologies, Inc. Company Overview 98
5.32.1 Gold Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 98
5.33 Harvard University Company Overview 99
5.33.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 99
5.34 HeartWare International, Inc. Company Overview 100
5.34.1 HeartWare International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
5.35 Jarvik Heart, Inc. Company Overview 122
5.35.1 Jarvik Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 122
5.36 LaunchPoint Technologies, Inc. Company Overview 126
5.36.1 LaunchPoint Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 126
5.37 Leviticus Cardio Ltd. Company Overview 127
5.37.1 Leviticus Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 127
5.38 Levram Medical Systems Ltd Company Overview 129
5.38.1 Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 129
5.39 Lonestar Heart, Inc. Company Overview 130
5.39.1 Lonestar Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.40 Mayo Clinic. Company Overview 135
5.40.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 135
5.41 MicroMed Cardiovascular, Inc. Company Overview 137
5.41.1 MicroMed Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.42 Microstim GmbH Company Overview 138
5.42.1 Microstim GmbH Pipeline Products & Ongoing Clinical Trials Overview 138
5.43 MyoCardioCare, Inc. Company Overview 139
5.43.1 MyoCardioCare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 139
5.44 MyoPowers Medical Technologies SA Company Overview 142
5.44.1 MyoPowers Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 142
5.45 NeoCardial Technologies, LLC Company Overview 143
5.45.1 NeoCardial Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 143
5.46 New Heart Company Overview 144
5.46.1 New Heart Pipeline Products & Ongoing Clinical Trials Overview 144
5.47 Nipro Corporation Company Overview 145
5.47.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 145
5.48 NuVascular Technologies Inc Company Overview 147
5.48.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 147
5.49 Orqis Medical Corporation Company Overview 148
5.49.1 Orqis Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 148
5.50 Penn State Milton S. Hershey Medical Center Company Overview 150
5.50.1 Penn State Milton S. Hershey Medical Center Pipeline Products & Ongoing Clinical Trials Overview 150
5.51 Perfusion Solutions Company Overview 152
5.51.1 Perfusion Solutions Pipeline Products & Ongoing Clinical Trials Overview 152
5.52 PlugMed Heart SAS Company Overview 153
5.52.1 PlugMed Heart SAS Pipeline Products & Ongoing Clinical Trials Overview 153
5.53 Procyrion Company Overview 154
5.53.1 Procyrion Pipeline Products & Ongoing Clinical Trials Overview 154
5.54 Purdue University Company Overview 155
5.54.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 155
5.55 QRS Diagnostic, LLC Company Overview 157
5.55.1 QRS Diagnostic, LLC Pipeline Products & Ongoing Clinical Trials Overview 157
5.56 ReliantHeart, Inc. Company Overview 158
5.56.1 ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 158
5.57 Saint Louis University Company Overview 161
5.57.1 Saint Louis University Pipeline Products & Ongoing Clinical Trials Overview 161
5.58 St. Jude Medical, Inc. Company Overview 163
5.58.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 163
5.59 Sunshine Heart Company, Pty. Ltd. Company Overview 176
5.59.1 Sunshine Heart Company, Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 176
5.60 SynCardia Systems, Inc. Company Overview 182
5.60.1 SynCardia Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 182
5.61 Teleflex Incorporated Company Overview 194
5.61.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 194
5.62 Terumo Corporation Company Overview 196
5.62.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 196
5.63 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Company Overview 198
5.63.1 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Pipeline Products & Ongoing Clinical Trials Overview 198
5.64 The University of Tokyo Company Overview 199
5.64.1 The University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 199
5.65 U.S. Stem Cell, Inc. Company Overview 201
5.65.1 U.S. Stem Cell, Inc. Pipeline Products & Ongoing Clinical Trials Overview 201
5.66 University of Minnesota Company Overview 203
5.66.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 203
5.67 University of Zurich Company Overview 205
5.67.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 205
5.68 Vadovations, Inc. Company Overview 206
5.68.1 Vadovations, Inc. Pipeline Products & Ongoing Clinical Trials Overview 206
5.69 Vienna University of Technology Company Overview 207
5.69.1 Vienna University of Technology Pipeline Products & Ongoing Clinical Trials Overview 207
5.70 Windmill Cardiovascular Systems, Inc. Company Overview 208
5.70.1 Windmill Cardiovascular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 208
6 Cardiac Assist Devices- Recent Developments 209
7 Appendix 320
7.1 Methodology 320
7.2 About GlobalData 322
7.3 Contact Us 323
7.4 Disclaimer 323
【レポート販売概要】
■ タイトル：世界の心臓補助装置開発動向：医療機器パイプライン分析2015■ 英文：Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0142EPD
■ 調査対象地域：グローバル
- 健康保険の世界市場：プロバイダー別、保険種類別、カバレッジタイプ別、人口統計別、ネットワーク別The global health insurance market was valued at $3,153 billion in 2018, and is estimated to reach $4,475 billion by 2026, registering a CAGR of 4.4% from 2019 to 2026. Health insurance covers various Health expenses, including the routine of health examinations, unforeseen illnesses or injuries, inpatient & outpatient surgery, specialist referral visits, and prescription medications of insured pe …
- ブラジルのバイオ発電市場2016：発電能力、生産、投資動向、制度、企業Biopower in Brazil, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary "Biopower in Brazil, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles" is the latest report from GlobalData, the industry analysis …
- 世界のAMI（Advanced Metering Infrastructure：スマートメーター）市場予測及び分析Utility service provider companies face unique challenges in managing complex distribution networks for water, gas, and electricity. Apart from slip ups in managing smooth operational activities, these companies face numerous difficulties in managing the meter-to-cash cycle. Utility companies in the U.S. and some European countries like U.K. and France also have to aspire for customer retention an …
- 世界の対IED防衛市場動向2013-2023：市場規模及び成長要因The global counter IED market is estimated to value US$6.4 billion in 2012, and will decrease at a CAGR of 5.59% during the forecast period, to reach US$3.6 billion by 2022. The market consists of five categories: counter IED vehicles, electronic countermeasures, detection systems, unmanned systems, and counter IED training.
- 血栓塞栓症(Thromboembolism)の治療薬パイプライン動向（2015年上半期版）Thromboembolism - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H1 2015’, provides an overview of the Thromboembolism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thromboembolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of acti …
- Gas Turbines for Thermal Power, 2013 – Global Market Size, Average Pricing, Equipment Segmentation and Competitive Landscape Analysis to 2020Gas Turbines for Thermal Power, 2013 Update - Global Market Size, Average Pricing, Equipment Segmentation and Competitive Landscape Analysis to 2020 Summary The report provides an in depth analysis of gas turbine market in China, the US, India, Indonesia, the UK, Germany, Brazil and Saudi Arabia. This report analyzes the gas turbine market in terms of revenue forecasts, volume sales, equipment seg …
- PCIe（ピーシーアイエクスプレス）SSD（ソリッドステートドライブ）の世界市場2016-2020About Solid-State Drive A solid-state drive (SSD) is a kind of an electronic disk that is built out of silicon microchips and is used for data storage. It uses the same I/O interface design as hard disk drives and stores data in solid-state memory in the form of electric charge. It is made out of silicon microchips. Dynamic random access memory (DRAM) and negated AND (NAND) are most commonly used …
- Seroquel XR (大うつ病性障害)：医薬品市場予測及び分析（～2023）Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries …
- 小売分析の世界市場：業務機能（マーケティング/顧客分析、マーチャンダイジング/インストア分析、サプライチェーン分析、戦略、企画）、種類、ソリューション、サービスMarketsandMarkets forecast the retail analytics market size growth from USD 2.2 Billion in 2015 to USD 5.1 Billion by 2020, at a compound annual growth rate (CAGR) of 18.9% from 2015 to 2020. Due to digitalization there is continuous rise in volume, variety and velocity of data in retail sector, and to analyze these data there is high demand for the solutions and services of retail analytics, driv …
- [Updated] グローバル戦場管理システム市場予測及び分析2014 – 2019The report provides an in-depth analysis of the global BMS market. It provides information about the current trends in the market with respect to geographies, countries, platforms, and, applications market scenario. It throws light on the current market trends, the drivers, and restraints of this market, and the challenges faced in the market that will impact the growth of this market. It analyzes …
- ラフテレーンフォークリフトトラック(RTLT)の世界市場2018-2022About rough terrain lift truck (RTLT) Rough terrain lift truck (RTLT) are powered industrial trucks designed to lift and transfer material over short distances. These trucks are equipped to run on unpaved and rough surfaces and are suitable for construction sites or military applications. Technavio’s analysts forecast the Global rough terrain lift truck (RTLT) market to grow at a CAGR of 2.14% dur …
- ミックスドシグナル・システムオンチップ（SoC）IPコアの世界市場About Semiconductor IP A semiconductor IP core or an IP block is a reusable unit of logic, a cell or a chip layout design that is the IP of a party. IP cores may be licensed to another party or owned and used by a single party alone. An IP core is used as a building block within application-specific integrated circuit chip designs or field-programmable gate array logic designs. An IP core can be d …
- モバイル端末のマネージドサービスの世界市場：モバイル端末管理(MDM)、モバイルアプリケーション管理(MAM)、モバイルセキュリティー管理(MSM)About Managed Mobility Services Managed services is the practice followed by enterprises to outsource the non-core activities of the business. The non-core activities of the business help businesses carry out their day-to-day operations and help in improving their operations and work in the most efficient way. Managed services may include HR activities, production support, and lifecycle build/main …
- 2014年戦略提言：日本の内分泌機能検査市場This new 269-page report from Venture Planning Group provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Es …
- 大気質モニターの世界市場2016-2020：政府部門、商用・住宅部門、エネルギー・製薬部門About Air Quality MonitorLocomotives, highway vehicles, and aircraft release pollution in the form of gases and particulate matters, which affects the air quality. CO emissions can harm the oxygen availability, NO₂ can affect lung functioning and immune system, SO₂ and NOx can lead to acid rain, which will damage crops and vegetation. Pollutants smog is formed with the mixture of CO, O₃, hydrocarb …
